PROCTER & GAMBLE HEALTH Fact Sheet, PROCTER & GAMBLE HEALTH Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH Fact Sheet    (EMER)


FREE Replay: See How Richa Picks Potentially Crorepati-Making Stocks...


Here is the latest financial fact sheet of PROCTER & GAMBLE HEALTH. For more details, see the PROCTER & GAMBLE HEALTH quarterly results and PROCTER & GAMBLE HEALTH share price and chart. For a sector overview, read our pharmaceuticals sector report.

PROCTER & GAMBLE HEALTH Price History

Price Rs 4,200.9
Mkt Cap Rs m 69,732
Vol '000 0.2
P/E X 37.6
P/CF X 33.7
EPS (TTM) Rs 111.6
1 Day % -1.4
No. of shares m 16.60
1 Week % -7.0
1 Month % -1.6
1 Year % -30.4
52 week H/L Rs 6,099.0/3,998.9
As on May 26, 2022 10:18:00 AM
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

PROCTER & GAMBLE HEALTH Financials

No. of Mths
Year Ending
12
Dec-16
*
12
Dec-17
*
12
Dec-18
*
12
Jun-20
*
12
Jun-21
*
5-Yr Chart
Click to enlarge
PROCTER & GAMBLE HEALTH EQUITY SHARE DATA
High Rs1,0601,3583,5495,1217,500 
Low Rs6239331,3012,9284,004 
Sales per share (Unadj.) Rs575.5412.5776.0816.8607.7 
Earnings per share (Unadj.) Rs47.756.6505.3153.1106.5 
Diluted earnings per shareRs47.756.6505.3153.1106.5 
Cash flow per share (Unadj.) Rs62.668.1518.0170.8124.6 
Dividends per share (Unadj.) Rs11.0015.00440.00230.00130.00 
Adj. dividends per shareRs11.0015.00440.02230.01130.00 
Avg Dividend yield %1.31.318.15.72.3 
Book value per share (Unadj.) Rs399.9441.7927.8544.8421.6 
Adj. book value per shareRs399.9441.7927.8544.8421.6 
Shares outstanding (eoy) m16.6016.6016.6016.6016.60 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x1.52.83.14.99.5 
Avg P/E ratio x17.720.24.826.354.0 
P/CF ratio (eoy) x13.416.84.723.646.2 
Price / Book Value ratio x2.12.62.67.413.6 
Dividend payout %23.126.587.1150.3122.1 
Avg Mkt Cap Rs m13,96819,01040,25666,80195,477 
No. of employees `000NANANANANA 
Total wages/salary Rs m1,5421,0991,3131,8291,505 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
PROCTER & GAMBLE HEALTH INCOME DATA
Net Sales Rs m9,5546,84812,88113,55910,087 
Other income Rs m2448377,223700181 
Total revenues Rs m9,7987,68520,10414,25810,268 
Gross profit Rs m1,1568762,1673,1432,460 
Depreciation Rs m248191211295300 
Interest Rs m00008 
Profit before tax Rs m1,1521,5229,1793,5492,333 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m3605837921,008565 
Profit after tax Rs m7919398,3872,5411,768 
Gross profit margin %12.112.816.823.224.4 
Effective tax rate %31.338.38.628.424.2 
Net profit margin %8.313.765.118.717.5 
PROCTER & GAMBLE HEALTH BALANCE SHEET DATA
Current assets Rs m7,5028,79318,89212,64810,389 
Current liabilities Rs m3,0053,5225,4775,3865,507 
Net working cap to sales %47.177.0104.153.648.4 
Current ratio x2.52.53.42.31.9 
Inventory Days Days191311163196289 
Debtors Days Days4165188256215 
Net fixed assets Rs m6,1316,3676,9358,4739,390 
Share capital Rs m166166166166166 
"Free" reserves Rs m6,4727,16715,2358,8786,832 
Net worth Rs m6,6387,33315,4019,0446,998 
Long term debt Rs m00000 
Total assets Rs m13,63315,16025,82621,12119,778 
Interest coverage x0000292.6 
Debt to equity ratio x00000 
Sales to assets ratio x0.70.50.50.60.5 
Return on assets %5.86.232.512.09.0 
Return on equity %11.912.854.528.125.3 
Return on capital %17.320.859.639.233.4 
Exports to sales %9.10000 
Imports to sales %20.912.410.816.914.5 
Exports (fob) Rs m8690000 
Imports (cif) Rs m2,0018521,3972,2901,462 
Fx inflow Rs m9591,0151,6362,1751,331 
Fx outflow Rs m2,6123,0434,3682,2901,462 
Net fx Rs m-1,653-2,028-2,732-115-131 
PROCTER & GAMBLE HEALTH CASH FLOW
From Operations Rs m 1,070 537 -1,304 2,354 2,473 
From Investments Rs m -750 -476 12,697 1,646 -323 
From Financial Activity Rs m -150 -220 -301 -8,834 -3,866 
Net Cashflow Rs m 171 -160 11,092 -4,834 -1,716 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 51.8%
Institution 14.5%
Non-Institution 33.7%
Total 100.0%
Free Float 48.2%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2022
 

Company Information

Regd Off Godrej One 8th Floor, Pirojshanagar, Eastern Express Highway Vikhroli (East), Mumbai - 400079
E-mail investorgrievance.im@pg.com Web www.pghealthindia.com
Tel 022 6866 9000 Fax 022 2518 6828
Sector PHARMACEUTICALS Group Merck - MNC
Tr Agent K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
Auditor B. S. R & Co.
CHM: Suresh N Talwar COMP SEC: Preeti Bishnoi YEAR OF INC: 1967 BSE CODE: 500126 FV (Rs): 10 DIV YIELD (%): 3.1

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    

Compare PROCTER & GAMBLE HEALTH With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    




Today's Market

Sensex Trades Marginally Higher; Power & FMCG Stocks Under Pressure(10:30 am)

Asian share markets are higher today following gains on Wall Street as investors looked at the optimistic side of Federal Reserve minutes that reiterated plans to raise interest rates.

Views on news

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far... (Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022 (Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022 (Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look... (Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better? (Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH - ACTAVIS COMPARISON

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS